Cargando…
P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428970/ http://dx.doi.org/10.1097/01.HS9.0000968844.13145.db |
| _version_ | 1785090598766641152 |
|---|---|
| author | Russell, Nigel Cumming, Oliver Othman, Jad Dillon, Richard Potter, Nicola Wilhelm-Benartzi, Charlotte Jovanovic, Jelena Gilkes, Amanda Batten, Leona Canham, Joanna Laura Hinson, Emily Kottaridis, Panagiotis Cavenagh, Jamie Arnold, Claire Dennis, Mike Knapper, Steven |
| author_facet | Russell, Nigel Cumming, Oliver Othman, Jad Dillon, Richard Potter, Nicola Wilhelm-Benartzi, Charlotte Jovanovic, Jelena Gilkes, Amanda Batten, Leona Canham, Joanna Laura Hinson, Emily Kottaridis, Panagiotis Cavenagh, Jamie Arnold, Claire Dennis, Mike Knapper, Steven |
| author_sort | Russell, Nigel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289702023-08-17 P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL Russell, Nigel Cumming, Oliver Othman, Jad Dillon, Richard Potter, Nicola Wilhelm-Benartzi, Charlotte Jovanovic, Jelena Gilkes, Amanda Batten, Leona Canham, Joanna Laura Hinson, Emily Kottaridis, Panagiotis Cavenagh, Jamie Arnold, Claire Dennis, Mike Knapper, Steven Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428970/ http://dx.doi.org/10.1097/01.HS9.0000968844.13145.db Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Russell, Nigel Cumming, Oliver Othman, Jad Dillon, Richard Potter, Nicola Wilhelm-Benartzi, Charlotte Jovanovic, Jelena Gilkes, Amanda Batten, Leona Canham, Joanna Laura Hinson, Emily Kottaridis, Panagiotis Cavenagh, Jamie Arnold, Claire Dennis, Mike Knapper, Steven P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title | P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title_full | P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title_fullStr | P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title_full_unstemmed | P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title_short | P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT TRIAL |
| title_sort | p484: gemtuzumab-based induction chemotherapy combined with midostaurin for flt3 mutated aml. updated toxicity and interim survival analysis from the ncri aml19v2 “midotarg” pilot trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428970/ http://dx.doi.org/10.1097/01.HS9.0000968844.13145.db |
| work_keys_str_mv | AT russellnigel p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT cummingoliver p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT othmanjad p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT dillonrichard p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT potternicola p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT wilhelmbenartzicharlotte p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT jovanovicjelena p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT gilkesamanda p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT battenleona p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT canhamjoanna p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT laurahinsonemily p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT kottaridispanagiotis p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT cavenaghjamie p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT arnoldclaire p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT dennismike p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial AT knappersteven p484gemtuzumabbasedinductionchemotherapycombinedwithmidostaurinforflt3mutatedamlupdatedtoxicityandinterimsurvivalanalysisfromthencriaml19v2midotargpilottrial |